본문 바로가기
KERD
논문KCI 등재

파킨슨병에 동반된 수면질환의 임상적 특성

Clinical Characteristics of Sleep Disorders in Parkinson’s Disease

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류신경과학

초록

Background: Sleep disturbances are very common in the patients with Parkinson’s disease (PD) and several sleep disorders are known to have pathological associations with PD, such as REM sleep behavior disorder (RBD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). The authors conducted this study to find clinical characteristics and impact of sleep disorders in the patients with PD. Methods: A total of 97 patients with PD (41 males, age 61.0±9.3 years, Hoehn and Yahr stage 1-4) were recruited. We interviewed bed partners of parkinsonian patients for sleep disorders with structured questionnaires and compared interview results with the clinical characteristics of Parkinson’s disease and the results of cognitive function tests. Results: RLS (24.7%), RBD (19.6%), sleep apnea (15.5%) and PLMD (13.4%) were frequently reported by bed partners of the patients. PLMD, RBD and apnea were significantly increased in male patients. Parkinsonian characteristics of the patients (dose of L-dopa, predominant motor symptom, duration of symptom and treatment, use of dopamine agonist, Hoehn and Yahr stage, and severity of motor symptoms) were not related with sleep disorders and daytime sleepiness, but the bed partners reported decreased arousal and increased daytime sleepiness in the patients with sleep disorders. The cognitive profiles of the patients showed impaired memory function in the sleepy patients. Conclusions: We could not find the correlations between sleep disorders and the clinical characteristics of PD. But, sleep disorders were prevalent in PD patients and caused daytime sleepiness and cognitive dysfunctions.

Abstract

Background: Sleep disturbances are very common in the patients with Parkinson’s disease (PD) and several sleep disorders are known to have pathological associations with PD, such as REM sleep behavior disorder (RBD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). The authors conducted this study to find clinical characteristics and impact of sleep disorders in the patients with PD. Methods: A total of 97 patients with PD (41 males, age 61.0±9.3 years, Hoehn and Yahr stage 1-4) were recruited. We interviewed bed partners of parkinsonian patients for sleep disorders with structured questionnaires and compared interview results with the clinical characteristics of Parkinson’s disease and the results of cognitive function tests. Results: RLS (24.7%), RBD (19.6%), sleep apnea (15.5%) and PLMD (13.4%) were frequently reported by bed partners of the patients. PLMD, RBD and apnea were significantly increased in male patients. Parkinsonian characteristics of the patients (dose of L-dopa, predominant motor symptom, duration of symptom and treatment, use of dopamine agonist, Hoehn and Yahr stage, and severity of motor symptoms) were not related with sleep disorders and daytime sleepiness, but the bed partners reported decreased arousal and increased daytime sleepiness in the patients with sleep disorders. The cognitive profiles of the patients showed impaired memory function in the sleepy patients. Conclusions: We could not find the correlations between sleep disorders and the clinical characteristics of PD. But, sleep disorders were prevalent in PD patients and caused daytime sleepiness and cognitive dysfunctions.

참고문헌 (40)

  1. Chaudhuri KR, "National Institute for Clinical Exellence. Non-motor symptoms of Parkinson’s disease: diagnosis and management", Lancet Neurol, 5, pp.235~245 (2006)
  2. Hely MA, "Sydney Multicenter Study of Parkinson’s Disease: non-L-dopa-responsive problems dominate at 15 years", Mov Disord, 20, pp.190~199 (2005)
  3. Ahn T, "Sleep disturbance and Sleep-related Disorders in Parkinson’s Disease", J Korean Neurol Assoc, 20, pp.365~372 (2002)
  4. Tandberg E, "Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study", Mov Disord, 14, pp.922~927 (1999)
  5. Lees AJ, "The nighttime problems of Parkinson’s disease", Clin Neuropharmacol, 11, pp.512~519 (1988)
  6. Karlsen K, "Fatigue in patients with Parkinson’s disease", Mov Disord, 14, pp.237~241 (1999)
  7. Chaudhuri KR, "Nocturnal symptom complex in PD and its management", Neurology, 61, pp.17~23 (2003)
  8. Schenck CH, "Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder", Neurology, 46, pp.388~393 (1996)
  9. Arnulf I, "Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis", Neurology, 55, pp.281~288 (2000)
  10. Sinforiani E, "REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson’s disease", Mov Disord, 21, pp.462~466 (2006)
  11. Appiah-Kubi LS, "Restless legs syndrome (RLS), Parkinson’s disease, and sustained dopaminergic therapy for RLS", Sleep Med, 3, pp.51~55 (2002)
  12. Wetter TC, "Sleep and periodic leg movement patterns in drug free patients with Parkinson’s disease and multiple system atrophy", Sleep, 23, pp.361~367 (2000)
  13. Diederich NJ, "Sleep apnoea syndrome in Parkinson’s disease. A case-control study in 49 patients", Mov Disord, 20, pp.1413~1418 (2005)
  14. Fabbrini G, "Excessive daytime sleepiness in de novo and treated Parkinson’s disease", Mov Disord, 17, pp.1026~1030 (2002)
  15. van Hilten JJ, "Sleep, excessive daytime sleepiness and fatigue in Parkinson’s disease", J Neural Transm Park Dis Dement Sect, 5, pp.235~244 (1993)
  16. Hardie RJ, "Efthimiou J, Stern GM. Respiration and sleep in Parkinson’s disease", J Neurol Neurosurg Psychiatry, 49, pp.1326~ (1986)
  17. Paus S, "Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease", Mov Disord, 18, pp.659~667 (2003)
  18. Gjerstad MD, "Excessive daytime sleepiness in Parkinson’s disease: is it the drugs or the disease", Neurology, 67, pp.853~858 (2006)
  19. Comella CL, "Polysomnographic sleep measures in Parkinson’s disease patients with treatment-induced hallucinations", Ann Neurol, 34, pp.710~714 (1993)
  20. Hughes AJ, "A clinicopathologic study of 100 cases of Parkinson’s disease", Arch Neurol, 50, pp.140~148 (1993)
  21. Deuschl G, "A randomized trial of deep-brain stimulation for Parkinson’s disease", N Engl J Med, 355, pp.896~908 (2006)
  22. Hoehn MM, "Parkinsonism: onset, progression and mortality", Neurology, 17, pp.427~442 (1967)
  23. Fahn S, "Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB, Golstein M, eds. Recent development in Parkinson’s disease", Macmillan Health Care Information, 2, pp.153~164 (1987)
  24. Kang Y, "Seoul Neuropsychological Screening Battery" (2003), Human Brain Research & Consulting Co
  25. Boeve BF, "Petersen RC. Validation of a questionnaire for the diagnosis of REM sleep behavior disorder", Neurology, 58, pp.A509~ (2002)
  26. Kushida CA, "Practice parameters for the indications for polysomnography and related procedures: an update for 2005", Sleep, 28, pp.499~521 (2005)
  27. Cheon S, "Sleep disturbances in patients with Parkinson’s disease: Polysomnographic findings", J Korean Neurol Assoc, 23, pp.250~251 (2005)
  28. Lyons KE, "Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease", J Neurosurg, 104, pp.502~505
  29. Santamaria J, "How to evaluate excessive daytime sleepiness in Parkinson’s disease", Neurology, 63, pp.21~23 (2004)
  30. Back JS, "Parkinson’s disease sleep scale in Korea", J Korean Neurol Assoc, 23, pp.41~48 (2005)
  31. Kumar S, "Excessive daytime sleepiness in Parkinson’s disease as assessed by Epworth Sleepiness Scale (ESS)", Sleep Med, 4, pp.339~342 (2003)
  32. Frucht S, "Falling a sleep at the wheel: motor vehicle mishaps in patients taking pramipexole and ropinirole", Neurology, 52, pp.1908~1910 (1999)
  33. Schapira AH, "Sleep attacks (sleep episodes) with pergolide", Lancet, 355, pp.1332~1333 (2000)
  34. Ulivelli M, "Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD", Neurology, 58, pp.462~465 (2002)
  35. Happe S, "Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson’s disease", J Neurol, 254, pp.1037~1043 (2007)
  36. Thannickal TC, "Hypocretin (orexin) cell loss in Parkinson’s disease", Brain, 130, pp.1586~1595 (2007)
  37. Saunamaki T, "A review of executive functions in obstructive sleep apnea syndrome", Acta Neurol Scand, 115, pp.1~11 (2007)
  38. Sateia MJ, "Neuropsychological impairment and quality of life in obstructive sleep apnea", Clin Chest Med, 24, pp.249~259 (2003)
  39. Beebe DW, "Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits", J Sleep Res, 11, pp.1~16 (2002)
  40. Jo H, "REM sleep behavior in patients with Parkinson’s disease", J Korean Neurol Assoc, 23, pp.250~ (2005)

관련 논문AI추천

이 간행물의 다른 논문 (19건)